Step Therapy and Prior Authorization for Migraine Drugs: How to Get Past Them
What insurers require before covering CGRP drugs and gepants, the exceptions state and federal rules give you, and how to build a request that gets approved.
On this pageJump to a section7
What These Two Terms Mean
- Prior authorization means your plan wants to approve a drug before it will pay. Your physician's office submits a form with your diagnosis and history.
- Step therapy, sometimes called fail first, means the plan wants you to try one or more cheaper drugs before it will cover the one that was prescribed.
Most plans apply both to the newer migraine drugs. Neither is a refusal. They are checklists, and the job is to show that you meet the checklist or qualify for an exception.
What Plans Usually Require for Migraine Drugs
| Drug type | Common requirements |
|---|---|
| CGRP antibodies and preventive gepants | A diagnosis of migraine with at least 4 migraine days a month, and a trial of two or more older preventives from different classes, such as topiramate, a beta blocker, amitriptyline or venlafaxine |
| Gepants for acute treatment | A trial of two triptans, or a reason triptans cannot be used |
| OnabotulinumtoxinA | Chronic migraine, meaning 15 or more headache days a month, and a trial of two or more oral preventives |
| Renewals | Proof of benefit after 3 to 6 months, usually a drop in monthly migraine days or an improved disability score |
Each plan publishes its own criteria. Search the plan's website for the drug name plus the words clinical policy or prior authorization criteria, or ask the plan to send them. Read them before the request goes in.
The American Headache Society's 2024 position statement says CGRP-targeting drugs should be considered a first-line option for prevention and that people should not have to fail other drugs first. Insurers are not bound by that statement, but it belongs in every request and appeal.
One limit is specific to migraine. Many plans will not cover two CGRP-targeting drugs at once, such as an antibody for prevention with a gepant for attacks, or a CGRP drug together with onabotulinumtoxinA. If your physician prescribes a combination, the request should say why one treatment alone was not enough.
What Counts as Having Tried a Drug
You do not have to suffer through a full course of a drug that is harming you. The American Headache Society's 2021 consensus statement describes an adequate preventive trial as at least 8 weeks at a dose that could be effective. It also counts a drug as failed when you could not tolerate it or when it is contraindicated for you.
For each drug you have tried, your chart should show four things.
- The name and the highest dose you reached
- Start and stop dates
- The reason you stopped, either no benefit, a side effect or a safety concern
- Who prescribed it, including physicians you saw under an earlier insurance plan
If you cannot remember, your pharmacy can print your fill history, and former clinics can send records. Write it up on one page and hand it to the staff member who files authorizations. The doctor visit summary has a place for past treatments.
Grounds for a Step Therapy Exception
As of 2026, 38 states and the District of Columbia have laws that require insurers to offer a clear exception process and to answer on a deadline, typically 72 hours and 24 hours in urgent cases. The details vary, but most of these laws require the plan to grant an exception in situations like the ones below.
Illinois went further and banned step therapy in state-regulated plans starting in 2026.
| Ground | Migraine examples |
|---|---|
| The required drug is contraindicated or likely to cause harm | Valproate or topiramate for someone who is or could become pregnant. Beta blockers with asthma or a slow heart rate. Tricyclics with certain heart rhythm problems. Triptans with coronary artery disease, prior stroke or uncontrolled high blood pressure. |
| The required drug is expected to be ineffective | A drug in the same class as one that already failed |
| You already tried it | A trial under a previous plan or years ago counts if it is documented |
| You are stable on the prescribed drug | You changed jobs or plans while doing well on a CGRP drug and the new plan wants you to go back and fail older ones |
| The required drug is not in your best interest | Side effects that would keep you from working or driving, such as the cognitive slowing some people get with topiramate |
State step therapy laws apply to plans regulated by the state. About two thirds of workers with employer coverage are in self-funded plans, which fall under federal law and are exempt. The Safe Step Act would extend similar protections to those plans. It has been introduced in Congress as S. 2903 and H.R. 5509 and has not passed. If you are in a self-funded plan, you still have the federal appeal rights described in how to appeal a denial, and your employer's benefits team can ask the administrator to make an exception.
Medicare and Medicaid
- Medicare Part D. You or your prescriber can ask for a coverage determination or an exception. Once the plan has your prescriber's supporting statement, it must decide within 72 hours, or 24 hours if the request is expedited.
- New to a Part D plan? Plans must give a temporary transition supply of a drug you were already taking, generally one month's fill during your first 90 days, so you have time to request an exception.
- Medical services. Starting in 2026, a federal rule requires Medicare Advantage, Medicaid and CHIP plans to answer standard prior authorization requests within 7 calendar days and expedited ones within 72 hours, and to give a specific reason for any denial. The rule covers medical items and services. It does not cover prescription drugs.
- Medicaid. Each state keeps a preferred drug list. Federal law requires a response to drug prior authorization requests within 24 hours and a 72-hour emergency supply when needed.
How to Get a Request Approved
- Find out who files it. Most clinics have one person who handles authorizations. Learn their name and ask what they need from you.
- Give them your treatment history on one page. Incomplete history is the most common reason for a first denial.
- Bring numbers. Monthly headache days and migraine days for the last three months, plus a MIDAS or HIT-6 score.
- Name the exception ground. If a required drug is unsafe for you, the request should say so in plain words and cite the reason.
- Ask for expedited review when it applies. Your physician can state that a delay would seriously jeopardize your health or leave you in severe pain.
- Track the clock. Write down the date the request went in and call on the day the deadline passes. In some states, a request the plan fails to answer on time is treated as approved.
- Ask for a peer-to-peer review if it is denied. Your physician can request a phone call with the plan's medical reviewer. Plans set their own window for this and it can be short, so ask the office to request it the day the denial arrives.
- Keep the diary going after approval. You will need it for the renewal.
While you wait, ask about samples and manufacturer bridge programs. See how to lower the cost of migraine medication.
Since January 2026 most large insurers have pledged to honor an existing prior authorization for 90 days when you switch to a new plan, as long as the drug is a covered benefit there. The pledge is voluntary and has no enforcement behind it, so ask the new plan in writing whether it will honor your approval, and start a new request right away.
- Prior authorization and step therapy are checklists. Get the plan's criteria and answer each item.
- A drug you could not tolerate, or one that is unsafe for you, counts as a failed step.
- Most states require an exception process with a 72-hour answer, but self-funded employer plans are exempt.
- Medicare Part D must answer exception requests in 72 hours, or 24 hours when expedited.
- A one-page treatment history with dates and reasons prevents most first denials.
This article is general information for people in the United States. It is not legal, financial or medical advice, and I am not a lawyer. Laws, dollar amounts and deadlines change, and your state or plan may have different rules. Check the official sources listed below, and talk with a qualified attorney, benefits counselor or your physician about your own situation.
References
- Charles AC, Digre KB, Goadsby PJ, et al. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache. 2024;64(4):333-341. doi:10.1111/head.14692
- Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039. doi:10.1111/head.14153
- American Bar Association Health Law Section. State Step Therapy Laws and ERISA: An Overview. 2026.
- Centers for Medicare and Medicaid Services. CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F).
- Medicare.gov. Exceptions and coverage determinations for Medicare drug plans. 42 C.F.R. 423.568 to 423.578.
- KFF. Employer Health Benefits Survey, 2025. Share of covered workers in self-funded plans.
- Safe Step Act, S. 2903 and H.R. 5509, 119th Congress.
- AHIP. Health Plans Take Action to Simplify Prior Authorization. June 23, 2025.


This article is for education and is not medical advice. Talk with your own clinician before starting, stopping or changing any treatment.


